Antonio Liguori
- Hepatology top 5%
- Liver Disease and Transplantation 11
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Liver Diseases and Immunity 3
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 26
- Periodontics top 10%
-
- Diet, Metabolism, and Disease 4
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 4
-
- Pancreatitis Pathology and Treatment 3
-
- Diet and metabolism studies 3
- Co-authors
- Antonio GasbarriniLuca MieleAntonio GriecoGiuseppe MarroneMarco BiolatoEmmanuel TsochatzisM VirnoFabio De Gregorio
- Cited by
- HepatologyEpidemiologyPeriodontics
- Journals
- Cochrane Database of Systematic Reviews (1 paper)International Journal of Molecular Sciences (3 papers)Journal of Hepatology (1 paper)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Antonio Liguori
40 papers receiving 519 citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hepatology 134
- Epidemiology 278
- Periodontics 33
- Endocrinology, Diabetes and Metabolism 91
- Pharmacology 46
Countries citing papers authored by Antonio Liguori
This map shows the geographic impact of Antonio Liguori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Liguori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Liguori more than expected).
Fields of papers citing papers by Antonio Liguori
This network shows the impact of papers produced by Antonio Liguori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Liguori. The network helps show where Antonio Liguori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Liguori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 7 | |
| 3 | 2025 | 8 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | Non-invasive testing and risk-stratification in patients with MASLDbreakdown → | 2024 | 40 |
| 7 | 2024 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 10 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 37 | |
| 16 | 2020 | 30 | |
| 17 | 2020 | 8 | |
| 18 | 2019 | 10 | |
| 19 | Drug-induced liver injury 2017: the diagnosis is not easy but always to keep in mind. | 2017 | 27 |
| 20 | 2000 | 42 |
About Antonio Liguori
Antonio Liguori is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 46 papers that have together received 530 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Diet, Metabolism, and Disease (4 papers), Pancreatitis Pathology and Treatment (3 papers), Diet and metabolism studies (3 papers) and Liver Diseases and Immunity (3 papers). The work is most often cited by research in Hepatology (134 citations), Epidemiology (278 citations) and Periodontics (33 citations). Antonio Liguori has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Antonio Gasbarrini, Luca Miele, Antonio Grieco, Giuseppe Marrone, Marco Biolato, Emmanuel Tsochatzis, M Virno, Fabio De Gregorio, Raffaele Papa and Giorgio Pompa. Their work appears in journals such as Cochrane Database of Systematic Reviews, International Journal of Molecular Sciences and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.